ATRYS HEALTH (Germany) Today
| A2T Stock | EUR 3.06 0.02 0.66% |
Performance0 of 100
| Odds Of DistressLess than 50
|
ATRYS HEALTH is trading at 3.06 as of the 22nd of November 2024. This is a 0.66% up since the beginning of the trading day. The stock's lowest day price was 2.86. ATRYS HEALTH has 50 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for ATRYS HEALTH SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH is traded on Frankfurt Stock Exchange in Germany. More on ATRYS HEALTH SA
Moving together with ATRYS Stock
Moving against ATRYS Stock
Follow Valuation Daily Balance Of Power
Check how we calculate scores
ATRYS Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ATRYS HEALTH's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ATRYS HEALTH or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Health Management (View all Themes) |
| Business Concentration | Health Management, Biotechnology, Healthcare (View all Sectors) |
ATRYS HEALTH SA (A2T) is traded on Frankfurt Exchange in Germany and employs 2,397 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 330.53 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ATRYS HEALTH's market, we take the total number of its shares issued and multiply it by ATRYS HEALTH's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ATRYS HEALTH SA classifies itself under Healthcare sector and is part of Biotechnology industry.
ATRYS HEALTH SA has accumulated about 17.6 M in cash with (1.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51.
Check ATRYS HEALTH Probability Of Bankruptcy
ATRYS HEALTH SA Risk Profiles
Although ATRYS HEALTH's alpha and beta are two of the key measurements used to evaluate ATRYS HEALTH's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.68 | |||
| Standard Deviation | 2.25 | |||
| Variance | 5.06 | |||
| Risk Adjusted Performance | (0.03) |
ATRYS Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in ATRYS HEALTH without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Other Information on Investing in ATRYS Stock
ATRYS HEALTH financial ratios help investors to determine whether ATRYS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ATRYS with respect to the benefits of owning ATRYS HEALTH security.